Literature DB >> 30778825

IgA nephropathy: is a new approach beyond proteinuria necessary?

Eduardo Gutiérrez1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30778825     DOI： 10.1007/s00467-019-4202-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  26 in total

1.  HLA has strongest association with IgA nephropathy in genome-wide analysis.

Authors:  John Feehally; Martin Farrall; Anne Boland; Daniel P Gale; Ivo Gut; Simon Heath; Ashish Kumar; John F Peden; Patrick H Maxwell; David L Morris; Sandosh Padmanabhan; Timothy J Vyse; Anna Zawadzka; Andrew J Rees; Mark Lathrop; Peter J Ratcliffe
Journal:  J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 10.121

2.  Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases.

Authors:  A Koyama; M Igarashi; M Kobayashi
Journal:  Am J Kidney Dis       Date:  1997-04       Impact factor: 8.860

3.  Remission of Hematuria Improves Renal Survival in IgA Nephropathy.

Authors:  Angel M Sevillano; Eduardo Gutiérrez; Claudia Yuste; Teresa Cavero; Evangelina Mérida; Paola Rodríguez; Ana García; Enrique Morales; Cristina Fernández; Miguel Angel Martínez; Juan Antonio Moreno; Manuel Praga
Journal:  J Am Soc Nephrol       Date:  2017-06-07       Impact factor: 10.121

4.  The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults.

Authors:  Rosanna Coppo; Stéphan Troyanov; Roberta Camilla; Ronald J Hogg; Daniel C Cattran; H Terence Cook; John Feehally; Ian S D Roberts; Alessandro Amore; Charles E Alpers; Jonathan Barratt; Francois Berthoux; Stephen Bonsib; Jan A Bruijn; Vivette D'Agati; Giuseppe D'Amico; Steven N Emancipator; Francesco Emma; Franco Ferrario; Fernando C Fervenza; Sandrine Florquin; Agnes B Fogo; Colin C Geddes; Hermann J Groene; Mark Haas; Andrew M Herzenberg; Prue A Hill; Stephen I Hsu; J Charles Jennette; Kensuke Joh; Bruce A Julian; Tetsuya Kawamura; Fernand M Lai; Lei S Li; Philip K Li; Zhi H Liu; Sergio Mezzano; F Paolo Schena; Yasuhiko Tomino; Patrick D Walker; Haiyan Wang; Jan J Weening; Norishige Yoshikawa; Hong Zhang
Journal:  Kidney Int       Date:  2010-03-03       Impact factor: 10.612

5.  Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Authors:  Rosanna Coppo; Danilo Lofaro; Roberta R Camilla; Shubha Bellur; Daniel Cattran; H Terence Cook; Ian S D Roberts; Licia Peruzzi; Alessandro Amore; Francesco Emma; Laura Fuiano; Ulla Berg; Rezan Topaloglu; Yelda Bilginer; Loreto Gesualdo; Rosaria Polci; Malgorzata Mizerska-Wasiak; Yasar Caliskan; Sigrid Lundberg; Giovanni Cancarini; Colin Geddes; Jack Wetzels; Andrzej Wiecek; Magdalena Durlik; Stefano Cusinato; Cristiana Rollino; Milena Maggio; Manuel Praga; Hilde K Smerud; Vladimir Tesar; Dita Maixnerova; Jonathan Barratt; Teresa Papalia; Renzo Bonofiglio; Gianna Mazzucco; Costantinos Giannakakis; Magnus Soderberg; Diclehan Orhan; Anna Maria Di Palma; Jadwiga Maldyk; Yasemin Ozluk; Birgitta Sudelin; Regina Tardanico; David Kipgen; Eric Steenbergen; Henryk Karkoszka; Agnieszka Perkowska-Ptasinska; Franco Ferrario; Eduardo Gutierrez; Eva Honsova
Journal:  Pediatr Nephrol       Date:  2016-08-25       Impact factor: 3.714

6.  Genome-wide association study identifies susceptibility loci for IgA nephropathy.

Authors:  Ali G Gharavi; Krzysztof Kiryluk; Murim Choi; Yifu Li; Ping Hou; Jingyuan Xie; Simone Sanna-Cherchi; Clara J Men; Bruce A Julian; Robert J Wyatt; Jan Novak; John C He; Haiyan Wang; Jicheng Lv; Li Zhu; Weiming Wang; Zhaohui Wang; Kasuhito Yasuno; Murat Gunel; Shrikant Mane; Sheila Umlauf; Irina Tikhonova; Isabel Beerman; Silvana Savoldi; Riccardo Magistroni; Gian Marco Ghiggeri; Monica Bodria; Francesca Lugani; Pietro Ravani; Claudio Ponticelli; Landino Allegri; Giuliano Boscutti; Giovanni Frasca; Alessandro Amore; Licia Peruzzi; Rosanna Coppo; Claudia Izzi; Battista Fabio Viola; Elisabetta Prati; Maurizio Salvadori; Renzo Mignani; Loreto Gesualdo; Francesca Bertinetto; Paola Mesiano; Antonio Amoroso; Francesco Scolari; Nan Chen; Hong Zhang; Richard P Lifton
Journal:  Nat Genet       Date:  2011-03-13       Impact factor: 38.330

7.  Remission of proteinuria improves prognosis in IgA nephropathy.

Authors:  Heather N Reich; Stéphan Troyanov; James W Scholey; Daniel C Cattran
Journal:  J Am Soc Nephrol       Date:  2007-10-31       Impact factor: 10.121

8.  Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.

Authors:  Manuel Praga; Eduardo Gutiérrez; Ester González; Enrique Morales; Eduardo Hernández
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

9.  Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria.

Authors:  Eduardo Gutiérrez; Isabel Zamora; José Antonio Ballarín; Yolanda Arce; Sara Jiménez; Carlos Quereda; Teresa Olea; Jorge Martínez-Ara; Alfons Segarra; Carmen Bernis; Asunción García; Marian Goicoechea; Soledad García de Vinuesa; Jorge Rojas-Rivera; Manuel Praga
Journal:  J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 10.121

10.  Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.

Authors:  Rosanna Coppo; Stéphan Troyanov; Shubha Bellur; Daniel Cattran; H Terence Cook; John Feehally; Ian S D Roberts; Laura Morando; Roberta Camilla; Vladimir Tesar; Sigrid Lunberg; Loreto Gesualdo; Francesco Emma; Cristiana Rollino; Alessandro Amore; Manuel Praga; Sandro Feriozzi; Giuseppe Segoloni; Antonello Pani; Giovanni Cancarini; Magalena Durlik; Elisabetta Moggia; Gianna Mazzucco; Costantinos Giannakakis; Eva Honsova; B Brigitta Sundelin; Anna Maria Di Palma; Franco Ferrario; Eduardo Gutierrez; Anna Maria Asunis; Jonathan Barratt; Regina Tardanico; Agnieszka Perkowska-Ptasinska
Journal:  Kidney Int       Date:  2014-04-02       Impact factor: 10.612
View more
  1 in total

1.  Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.

Authors:  Joshua Y C Yang; Reuben D Sarwal; Fernando C Fervenza; Minnie M Sarwal; Richard A Lafayette
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.